hypoxia-inducible factor
Showing 1 - 25 of >10,000
Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)
Recruiting
- Anemia in Dialysis-dependent CKD Patients
-
Alexandria, EgyptAlexandria University
Oct 29, 2023
Total Antioxidant, Total Oxidant(Tos), Hypoxia Inducible
Not yet recruiting
- Carbon Monoxide Exposure
- low-flow anesthesia
- (no location specified)
Dec 18, 2022
Hemodialysis Complication Trial in Mansoura (pentoxifylline)
Not yet recruiting
- Hemodialysis Complication
-
Mansoura, EgyptMansoura University Hospital
Feb 2, 2023
Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A
Not yet recruiting
- Hif-1α Covid-19
- HiF-1 alpha measurement
- (no location specified)
Dec 14, 2021
Breast Cancer Trial in Baltimore (Digoxin)
Completed
- Breast Cancer
-
Baltimore, MarylandKimmel Cancer Center at Johns Hopkins
Jan 22, 2020
Normobaric Hypoxia, Hypoventilation, Normoxia Trial in Lisbon (Repeated sprint)
Not yet recruiting
- Normobaric Hypoxia
- +2 more
- Repeated sprint
-
Lisbon, PortugalFaculty of Human Kinetics
Nov 10, 2023
Rheumatoid Arthritis, Psoriatic Arthritis Trial in Oxford (Nanobubble drink)
Withdrawn
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Nanobubble drink
-
Oxford, United KingdomOxford University Hospitals NHS Trust
May 17, 2022
Diabetes Complications, Diabetes; Nephropathy (Manifestation) Trial in Stockholm (Roxadustat, Darbepoietin Alfa)
Not yet recruiting
- Diabetes Complications
- Diabetes; Nephropathy (Manifestation)
- Roxadustat
- Darbepoietin Alfa
-
Stockholm, SwedenCentre for diabetes
Apr 11, 2023
ST Elevation Myocardial Infarction Trial in Shanghai (Roxadustat)
Recruiting
- ST Elevation Myocardial Infarction
-
Shanghai, Shanghai, ChinaRuijin Hospital
Aug 31, 2021
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Not yet recruiting
- Hypoxia
- +3 more
- HIF 1α and LC3B expression and MMP-9 level
- (no location specified)
Apr 5, 2023
Breast Cancer Trial in Xining (Oxygen inhalation treatment group, Control group)
Recruiting
- Breast Cancer
- Oxygen inhalation treatment group
- Control group
-
Xining, Qinghai, ChinaQinghai University Affiliated Hospital
Oct 24, 2021
Carbohydrate, Hypoxia, Exercise Trial in Porto (Exercise in normoxia, Control diet, Exercise in hypoxia)
Recruiting
- Carbohydrate
- +3 more
- Exercise in normoxia
- +3 more
-
Porto, Portugal
- +1 more
Jul 20, 2022
Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Beijing, Beijing, China
- +16 more
Jun 2, 2023
Hypoxic and Normoxic Cerebral Oximetry Levels on Cognitive
Completed
- Cerebral Hypoxia
- +2 more
-
Düzce, Turkeyİlknur Suidiye Yorulmaz
Dec 7, 2022
Fibroblast Growth Factor 23 in Chronic Respiratory Failure
Not yet recruiting
- Chronic Respiratory Failure
- Dosage
- Cardiac echography
- (no location specified)
Feb 17, 2022
type1diabetes Trial in Zabrze (Exercise in hypoxia, Exercise in normoxia)
Completed
- type1diabetes
- Exercise in hypoxia
- Exercise in normoxia
-
Zabrze, Silesia, PolandDepartment of Internal Diseases, Diabetology and Cardiometabolic
Apr 27, 2022
Intra-articular Corticosteroid Injection on Synovial Fluid
Completed
- Rheumatoid Arthritis
- Psoriatic Arthritis
-
Oxford, Oxfordshire, United KingdomNuffield Orthopaedic Centre
Jan 25, 2023
Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)
Recruiting
- Solid Tumor
- +3 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Mar 14, 2022
MDS Trial (Roxadustat in combination with retinoic acid)
Not yet recruiting
- Myelodysplastic Syndromes
- Roxadustat in combination with retinoic acid
- (no location specified)
Aug 26, 2023
Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Recruiting
- Clear Cell Renal Cell Carcinoma
- No intervention was required for patients or control group in this study
-
Jinan, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Mar 7, 2022
Hypertension Trial in Lausanne (Intermittent hypoxia-hyperoxia conditioning, Placebo intervention)
Not yet recruiting
- Hypertension
- Intermittent hypoxia-hyperoxia conditioning
- Placebo intervention
-
Lausanne, VD, SwitzerlandISSUL
Oct 28, 2022